Inhalational therapies for the ICU

Current Opinion in Critical Care

Volumn 15, Issue 1, 2009, Pages 1-9

  Robinson, Bryce R H ^a   Athota, Krishna P ^a   Branson, Richard D ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Aerosolized antibiotics; Heliox; Helium; Inhaled nitric oxide; Prostacyclin; Prostaglandin

Indexed keywords

ACETYLCYSTEINE; ADRENALIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ATROPINE; BETA LACTAM ANTIBIOTIC; BRAMITOB; CARBON MONOXIDE; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DORNASE ALFA; EXPECTORANT AGENT; GENTAMICIN; GUAIFENESIN; HELIOX; HELIUM; LIDOCAINE; MUCOLYTIC AGENT; NALOXONE; NITRIC OXIDE; PLACEBO; POLYMYXIN; POLYMYXIN B; PROSTACYCLIN; RIFAMPICIN; SODIUM CHLORIDE; SURFACTANT; TOBRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ACINETOBACTER; ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; ANTIBIOTIC PROPHYLAXIS; ASTHMA; BRAIN HEMORRHAGE; BRONCHIECTASIS; BRONCHUS SECRETION; CELL PROTECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG PENETRATION; DRY POWDER; ENDOTRACHEAL TUBE; EXTRACORPOREAL OXYGENATION; HEART SURGERY; HEART TRANSPLANTATION; HEAT; HUMAN; HUMIDIFIER; HYPOTENSION; ISCHEMIA; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LAMINAR FLOW; LOW DRUG DOSE; LUNG DYSPLASIA; LUNG TRANSPLANTATION; MOISTURE; MONOTHERAPY; MULTIDRUG RESISTANCE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; OTOTOXICITY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PSEUDOMONAS; PSEUDOMONAS INFECTION; PULMONARY HYPERTENSION; REBOUND; REPERFUSION INJURY; RESUSCITATION; REVIEW; SINGLE DRUG DOSE; TACHYPHYLAXIS; TRACHEOBRONCHITIS; TURBULENT FLOW; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT OBSTRUCTION; VASODILATATION; VENTILATOR ASSOCIATED PNEUMONIA; VOMITING;

HUMANS; INTENSIVE CARE UNITS; RESPIRATORY THERAPY;

EID: 61449248368     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283220e34     Document Type: Review

References (57)

1. Geller DE, Konstan MW, Smith J, et al. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety. Pediatr Pulmonol 2007; 42:307-313.
2. Chuchalin A, Eszter C, Gyurkovics K, et al. A formulation of aerosolized tobramycin (Bramitob®) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection. Pediatr Drugs 2007; 9 (supp. 1):21-31.
3. Bilton D, Henig N, Morrissey B, Gotfried M. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infections in adult bronchiectasis. Chest 2006; 130:1503-1510.
4. Palmer LB, Smaldone GC, Chen JJ, et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008; 36:2008-2013.
5. Pereira GH, Muller PR, Levin AS. Salvage treatment of pneumonia and initial treatment of tracheobronchitis cause by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B. Clin Microbiol Infect 2007; 58:235-240.
6. Falagas ME, Siempos II, Bliziotis IA, Michalopoulos A. Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials. Crit Care 2006; 10:R123.
7. Falagas ME, Agrafiotis M, Athanassa Z, Siempos II. Administration of anti-biotics via the respiratory tract as monotherapy for pneumonia. Expert Rev Anti Infect Ther 2008; 6:447-452.
8. Claridge JA, Edwards NM, Swanson J, et al. Aerosolized ceftazidime prophylaxis against ventilator-associated pneumonia in high-risk trauma patients: results of a double-blind randomized study. Surg Infect 2007; 8:83-90.
9. Mohr AM, Sifri ZC, Horng HS, et al. Use of aerosolized amINOglycosides in the treatment of Gram-negative ventilator-associated pneumonia. Surg Infect 2007; 8:349-357.
10. Hallal A, Cohn SM, Namias N, et al. Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study. Surg Infect 2007; 8:73-81.
11. Ioannidou E, Siempos II, Falagas ME. Administration of antibiotics via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis. J Antimicrob Chemother 2007; 60:1216-1226.
12. Mastoraki A, Douka E, Kriaras I, et al. Pseudomonas aerugINOsa susceptible only to colistin in intensive care unit patients. Surg Infect 2008; 9:153-160.
13. Ouderkirk JP, Nord JA, Turett GS, Kislak JW. Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant Gram-negative bacteria. Antimicrob Agents Chemother 2003; 47:2659-2662.
14. Motaouakkil A, Charra B, Hachimi A, et al. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. J Infect 2006; 53:274-278.
15. Moss RB. Administration of aerosolized antibiotics in cystic fibrosis. Chest 2001; 120:107S-113S.
16. Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics 1998; 101:325-334.
17. Van Meurs KP, Wright LL, Ehrenkranz RA, et al. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med 2005; 353:13-22.
18. Ballard RA, Truog WE, Cnaan A, et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 2006; 355:343-353.
19. Kinsella JP, Cutter GR, Walsh WF. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 2006; 355:354-364.
20. Su PH, Chen JY. Inhaled nitric oxide in the management of preterm infants with severe respiratory failure. J Perinatol 2008; 28:112-116.
21. Barrington KJ, Finer NN. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev 2007:CD000509.
22. George I, Xydas S, Topkara VK, et al. Clinical indication for use and outcomes after inhaled nitric oxide therapy. Ann Thorac Surg 2006; 82:2161-2169.
23. Adhikari NK, Burns KE, Friedrich JO, et al. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ 2007; 334:779.
24. van Heerden PV, Barden A, Michalopoulos N, et al. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS. Chest 2000; 117:819-827.
25. Voswinckel R, Enke B, Reichenberger F, et al. Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies. J Am Coll Cardiol 2006; 48:1672-1681.
26. Harris KW, O'Riordan TG, Smaldone GC. Aerosolized ilprost customized for the critically ill. Respir Care 2007; 52:1507-1509.
27. Zwissler B, Kemming G, Habler O, Kleen M, et al. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154:1671-1677.
28. Camamo JM, McCoy RH, Erstad BL. Retrospective evaluation of inhaled prostaglandins in patients with acute respiratory distress syndrome. Pharmacotherapy 2005; 25:84-190.
29. Kemper KJ, Ritz RH, Benson MS, et al. Helium-oxygen mixture in the treatment of postextubation stridor in pediatric trauma patients. Crit Care Med 1991; 19:356-359.
30. Vorwerk C, Coats T. Best evidence topic reports: heliox in croup. Emerg Med J 2008; 25:365-366.
31. Manthous CA, Hall JB, Caputo MA, et al. Heliox improves pulsus paradoxus and peak expiratory flow in nonintubated patients with severe asthma. Am J Respir Crit Care Med 1995; 151:310-314.
32. Gluck EH, Onorato DJ, Castriotta R. Helium-oxygen mixtures in intubated patients with status asthmaticus and respiratory acidosis. Chest 1990; 98:693-698.
33. Kumar D, Saksens RK. Use of heliox in the management of acute exacerbation of COPD. Emerg Med J 2007; 24:45-48.
34. Colebourn CL, Barber V, Young JD. Use of helium-oxygen mixture in adult patients presenting with exacerbations of asthma and chronic obstructive pulmonary disease: a systematic review. Anaesthesia 2007; 62:34-42.
35. Yanney M, Vyas H. The treatment of bronchiolitis. Arch Dis Child 2008; 93:793-798.
36. Cambonie G, Milesi C, Fournier-Favre S, et al. Clinical effects of heliox administration for acute bronchiolitis in young infants. Chest 2006; 129:676-682.
37. Liet JM, Millotte B, Tucci M, et al. Noninvasive therapy with helium-oxygen for severe bronchiolitis. J Pediatr 2005; 147:812-817.
38. Piantadosi CA. Carbon monoxide, reactive oxygen signaling, and oxidative stress. Free Radic Biol Med 2008; 45:562-569.
39. Bilban M, Haschemi A, Wegiel B, et al. Heme oxygenase and carbon monoxide initiate homeostatic signaling. J Mol Med 2008; 86:267-279.
40. The International Liaison Committee on Resuscitation. The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support. Pediatrics 2006; 117:e955-e977.
41. Branson RD. Secretion management in the mechanically ventilated patient. Respir Care 2007; 52:1328-1342.
42. Ricard JD, Le Miare E, Markowicz P, et al. Efficiency and safety of mechanical ventilation with a heat and moisture exchanger changed only once a week. Am J Respir Crit Care Med 2000; 161:104-109.
43. Villafane MC, Cinnella G, Lofaso F, et al. Gradual reduction of endotracheal tube diameter during mechanical ventilation via different humidification devices. Anesthesiology 1996; 85:1341-1349.
44. Boque MC, Gualis B, Sandiumenge A, Rello J. Endotracheal tube intraluminal diameter narrowing after mechanical ventilation: use of acoustic reflectometry. Intensive Care Med 2004; 30:2204-2209.
45. Shah C, Kollef MH. Endotracheal tube intraluminal volume loss among mechanically ventilated patients. Crit Care Med 2004; 32:120-125.
46. Jaber S, Pigeot J, Fodil R, et al. Long-term effects of different humidification systems on endotracheal tube patency: evaluation by the acoustic reflection method. Anesthesiology 2004; 100:782-788.
47. Hess DR. And now for the rest of the story [letter]. Respir Care 2002; 47:696-699.
48. Rumbak MJ, Walsh FW, Anderson WM, et al. Significant tracheal obstruction causing failure to wean in patients requiring prolonged mechanical ventilation: a forgotten complication of long-term mechanical ventilation. Chest 1999; 115:1092-1095.
49. Kirton OC, Banner MJ, Axelrad A, Drugas G. Detection of unsuspected imposed work of breathing: case reports. Crit Care Med 1993; 21:790-795.
50. Kirton OC, DeHaven CB, Morgan JP, et al. Elevated imposed work of breathing masquerading as ventilator weaning intolerance. Chest 1995; 108:1021-1025.
51. Celik SA, Kanan N. A current conflict: use of isotonic sodium chloride solution on endotracheal suctioning in critically ill patients. Dimens Crit Care Nurs 2006; 25:11-14.
52. Ridling DA, Martin LD, Bratton SL. Endotracheal suctioning with or without instillation of isotonic sodium chloride solution in critically ill children. Am J Crit Care 2003; 12:212-219.
53. Akgul S, Akyolcu N. Effects of normal saline on endotracheal suctioning. J Clin Nurs 2002; 11:826-830.
54. Morrow BM, Futter MJ, Argent AC. Endotracheal suctioning: from principles to practice. Intensive Care Med 2004; 30:1167-1174.
55. Rogers DF. Mucoactive agents for airway mucus hypersecretory diseases. Respir Care 2007; 52:1176-1193.
56. Restepro R. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance? Respir Care 2007; 52:1159-1173.
57. O'Riordan TG, Mao W, Palmer LB, Chen JJ. Assessing the effects of racemic and single-enantiomer albuterol on airway secretions in long-term intubated patients. Chest 2006; 129:124-132.